Future of Diagnostics: Thierry Bernard, Chief Executive Officer, Qiagen

HLTH Forward Podcast

Diagnostics play a critical role in healthcare. Predicting and preventing diseases early can reduce healthcare costs, reduce emotional stress, and improve precision care and medicine. The future of diagnostics lies at the intersection of good governance, innovation, social impact, and humanity.
The global Digital Diagnostics market size was valued at USD 458.57 million in 2021-2022 and is expected to expand at a CAGR of 26.23% during the forecast period, reaching USD 1855.5 million by 2030.
In this episode, I am in conversation with Thierry Bernard, Chief Executive Officer at Qiagen. We discuss the importance of good diagnostics in our lives and the power of R&D and products that can be launched at an accelerated rate to transform lives and sometimes save lives. Thierry shares his excitement about his vision of making diagnostic kits accessible, affordable, and innovative by harnessing emerging technologies.
He shares that, Qiagen has created an ecosystem where technology is part of each person's DNA and has been seamlessly integrated into the art of making products by launching a university focused on AI education, as he firmly believes that one has to walk the talk and it starts with education and all inclusive integrated knowledge-based talent management.
While we share our passion for creating products for the public good, Thierry enforces that we need empathy, inclusivity, and good partnerships to excel in healthcare.
About
Thierry Bernard joined QIAGEN in February 2015 to lead the company’s growing presence in molecular diagnostics, the application of Sample to Insight solutions for molecular testing in human healthcare. He was named Chief Executive Officer in March 2020 after serving in this role on an interim basis and became a member of the Managing Board in 2021. Previously, Mr. Bernard held roles of increasing responsibility during 15 years with bioMérieux SA, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region, and held senior management roles in several other leading international companies. He has been a member of the Board of Directors of T2 Biosystems, Inc., a publicly listed company based in the U.S., since 2020. He was named in March 2023 as Chair of the AdvaMedDx Board of Directors, a U.S. industry trade association. Mr. Bernard has earned degrees and certifications from Sciences Po, LSE, the College of Europe, Harvard Business School, Centro de Comercio Exterior de Barcelona, and has been appointed Conseiller du Commerce Extérieur by the French government.
About Host
Smriti Kirubanandan has a strong background in robotics and public health and is a Healthcare Executive, where she focuses on driving significant transformations within the healthcare ecosystem, concentrating on customer experience, intelligent automation, data analytics and insights, and is determined to make healthcare more accessible and affordable through innovation and empathy. She also spearheads brand development, thought leadership, and market research.
Smriti is a selected Young Global Leader 2023 by the World Economic Forum, a member of the Young Leaders Circle at the Milken Institute, and is the Founder of HLTH Forward Podcast- an award-winning media platform that hosts healthcare leaders, policymakers, and artists to discuss the challenges in the system and what we could do collectively to move healthcare forward.

Support the Show.